Yıl: 2021 Cilt: 5 Sayı: 3 Sayfa Aralığı: 322 - 328 Metin Dili: İngilizce DOI: 10.14744/ejmi.2021.70558 İndeks Tarihi: 17-02-2022

Understanding Breast Cancer From the Patients’ Perspective

Öz:
Objectives: We performed this study to seek what patients think about their diagnosis, treatment process and survi vorship. Methods: We evalued 125 breast cancer patients receiving chemotherapy in a descriptive and prospective study usinga well-structured questionnaire. Results: Most of the patients had information about breast cancer screening at the time of the questionnaire (57.6%),but the proportion of those who had prior knowledge of the disease was low (29.6%). While the most frequent signof breast cancer was reported to be a palpable mass (53.6%), the most frequent detection method was breast self examination (67.2%). The most frequent adverse effect of chemotherapy were reported to be hair loss (98.4%). Patients’expectations regarding the disease and adverse events were mostly stated as “I will be completely cured” (79.2% and53.6%, respectively). Etiological factor most frequently accepted by the patients were stress (85.6%). Most of the pa tients received support from their families during the course of the disease (91.2%). Conclusion: This study provides important new information for every stage of the fight against breast cancer from theperspective of cancer patients. These findings are useful for new programs and clinical decision-making.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Bibliyografik
  • 1. National Cancer Institute. Cancer stat facts: female breast cancer. Available at: https://seer.cancer.gov/statfacts/html/ breast.html. Accessed May 16, 2021.
  • 2. American Cancer Society. Cancer prevention and early detection, 2014. Available at: http://www.cancer.org/cancer/ breastcancer/moreinformation/ breastcancerearlydetection/ index. Accessed Dec 18, 2020.
  • 3. Falchetto R. The patient perspective: a matter of minutes. Patient - Patient-Centered Outcomes Res 2020;13:1–6. [CrossRef]
  • 4. van Overbeeke E, Whichello C, Janssens R, Veldwijk J, Cleemput I, Simoens S, et al. Factors and situations influencing the value of patient preference studies along the medical product lifecycle: a literature review. Drug Discov Today 2019;24:57– 68. [CrossRef]
  • 5. Ferrante M, Castiglione M, Zappalà G, Fiore M. Breast cancer screening, risk factors and simptoms awareness among sicilian women: Maria Fiore. Eur J Public Health 2017;27(suppl_3): ckx189.002. [CrossRef]
  • 6. Malak AT, Dicle A. Assessing the efficacy of a peer education model in teaching breast self-examination to university students. Asian Pac J Cancer Prev 2007;8:481–4.
  • 7. U.S. Preventive Services Task Force Final recommendation statement breast cancer: screening 2016. Available at: https:// www.uspreventiveservicestaskforce.org/uspstf/announcements/final-recommendation-statement-screening-breastcancer. Accessed Aug 7, 2020.
  • 8. Oeffinger KC, Fontham ETH, Etzioni R, Herzig A, Michaelson JS, Shih YC, et al. Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society. JAMA 2015;314:1599–614. [CrossRef]
  • 9. Josefson D. Breast self examination does not improve cancer survival. BMJ Br Med J 2002;12;325:793. [CrossRef]
  • 10. Kalliguddi S, Sharma S, Gore CA. Knowledge, attitude, and practice of breast self-examination amongst female IT professionals in Silicon Valley of India. J Fam Med Prim care 2019;8:568–72. [CrossRef]
  • 11. McMenamin M, Barry H, Lennon AM, Purcell H, Baum M, Keegan D, et al. A survey of breast cancer awareness and knowledge in a Western population: lots of light but little illumination. Eur J Cancer 2005;41:393–7. [CrossRef]
  • 12. Biçen Yılmaz H, Aksüyek H. Bursa ilinde meme kanserinin erken tanısında farkındalığın önemi-alan çalışması. Meme Sağlığı Derg 2012;8:76–80.
  • 13. Perry S, Kowalski TL, Chang C-H. Quality of life assessment in women with breast cancer: benefits, acceptability and utilization. Health Qual Life Outcomes 2007;5:24. [CrossRef]
  • 14. Seidman AD, Portenoy R, Yao TJ, Lepore J, Mont EK, Kortmansky J, et al. Quality of life in phase II trials: a study of methodology and predictive value in patients with advanced breast cancer treated with paclitaxel plus granulocyte colony-stimulating factor. J Natl Cancer Inst 1995;87:1316–22. [CrossRef]
  • 15. Ozalp E, Soygür H, Cankurtaran E, Turhan L, Akbiyik D, Geyik P. Psychiatric morbidity and its screening in Turkish women with breast cancer: a comparison between the HADS and SCID tests. Psychooncology 2008;17:668–75. [CrossRef]
  • 16. Henry DH, Viswanathan HN, Elkin EP, Traina S, Wade S, Cella D. Symptoms and treatment burden associated with cancer treatment: results from a cross-sectional national survey in the U.S. Support care cancer Off J Multinatl Assoc Support Care Cancer 2008;16:791–801. [CrossRef]
  • 17. Gadisa DA, Assefa M, Tefera GM, Yimer G. Patterns of anthracycline-based chemotherapy-ınduced adverse drug reactions and their ımpact on relative dose ıntensity among women with breast cancer in ethiopia: a prospective observational study. J Oncol 2020;2020:2636514. [CrossRef]
  • 18. Trüeb RM. Chemotherapy-induced alopecia. Curr Opin Support Palliat Care 2010;4:281–4. [CrossRef]
  • 19. Yeager CE, Olsen EA. Treatment of chemotherapy-induced alopecia. Dermatol Ther 2011;24:432–42. [CrossRef]
  • 20. Coates A, Abraham S, Kaye SB, Sowerbutts T, Frewin C, Fox RM, et al. On the receiving end--patient perception of the side-effects of cancer chemotherapy. Eur J Cancer Clin Oncol 1983;19:203–8. [CrossRef]
  • 21. Kiebert GM, Hanneke J, de Haes CJ, Kievit J, van de Velde CJ. Effect of peri-operative chemotherapy on the quality of life of patients with early breast cancer. Eur J Cancer 1990;26:1038– 42. [CrossRef]
  • 22. Lemieux J, Maunsell E, Provencher L. Chemotherapy-induced alopecia and effects on quality of life among women with breast cancer: a literature review. Psychooncology 2008;17:317–28. [CrossRef
APA CAVDAR E, iriagac Y, Karaboyun K, Avci O, SEBER E (2021). Understanding Breast Cancer From the Patients’ Perspective. , 322 - 328. 10.14744/ejmi.2021.70558
Chicago CAVDAR Eyyüp,iriagac Yakup,Karaboyun Kubilay,Avci Okan,SEBER Erdoğan Selçuk Understanding Breast Cancer From the Patients’ Perspective. (2021): 322 - 328. 10.14744/ejmi.2021.70558
MLA CAVDAR Eyyüp,iriagac Yakup,Karaboyun Kubilay,Avci Okan,SEBER Erdoğan Selçuk Understanding Breast Cancer From the Patients’ Perspective. , 2021, ss.322 - 328. 10.14744/ejmi.2021.70558
AMA CAVDAR E,iriagac Y,Karaboyun K,Avci O,SEBER E Understanding Breast Cancer From the Patients’ Perspective. . 2021; 322 - 328. 10.14744/ejmi.2021.70558
Vancouver CAVDAR E,iriagac Y,Karaboyun K,Avci O,SEBER E Understanding Breast Cancer From the Patients’ Perspective. . 2021; 322 - 328. 10.14744/ejmi.2021.70558
IEEE CAVDAR E,iriagac Y,Karaboyun K,Avci O,SEBER E "Understanding Breast Cancer From the Patients’ Perspective." , ss.322 - 328, 2021. 10.14744/ejmi.2021.70558
ISNAD CAVDAR, Eyyüp vd. "Understanding Breast Cancer From the Patients’ Perspective". (2021), 322-328. https://doi.org/10.14744/ejmi.2021.70558
APA CAVDAR E, iriagac Y, Karaboyun K, Avci O, SEBER E (2021). Understanding Breast Cancer From the Patients’ Perspective. Eurasian Journal of Medical Investigation, 5(3), 322 - 328. 10.14744/ejmi.2021.70558
Chicago CAVDAR Eyyüp,iriagac Yakup,Karaboyun Kubilay,Avci Okan,SEBER Erdoğan Selçuk Understanding Breast Cancer From the Patients’ Perspective. Eurasian Journal of Medical Investigation 5, no.3 (2021): 322 - 328. 10.14744/ejmi.2021.70558
MLA CAVDAR Eyyüp,iriagac Yakup,Karaboyun Kubilay,Avci Okan,SEBER Erdoğan Selçuk Understanding Breast Cancer From the Patients’ Perspective. Eurasian Journal of Medical Investigation, vol.5, no.3, 2021, ss.322 - 328. 10.14744/ejmi.2021.70558
AMA CAVDAR E,iriagac Y,Karaboyun K,Avci O,SEBER E Understanding Breast Cancer From the Patients’ Perspective. Eurasian Journal of Medical Investigation. 2021; 5(3): 322 - 328. 10.14744/ejmi.2021.70558
Vancouver CAVDAR E,iriagac Y,Karaboyun K,Avci O,SEBER E Understanding Breast Cancer From the Patients’ Perspective. Eurasian Journal of Medical Investigation. 2021; 5(3): 322 - 328. 10.14744/ejmi.2021.70558
IEEE CAVDAR E,iriagac Y,Karaboyun K,Avci O,SEBER E "Understanding Breast Cancer From the Patients’ Perspective." Eurasian Journal of Medical Investigation, 5, ss.322 - 328, 2021. 10.14744/ejmi.2021.70558
ISNAD CAVDAR, Eyyüp vd. "Understanding Breast Cancer From the Patients’ Perspective". Eurasian Journal of Medical Investigation 5/3 (2021), 322-328. https://doi.org/10.14744/ejmi.2021.70558